U.S. Markets closed

Coronavirus Is No Ebola, and That Presents a Different Problem

Michelle Cortez and Robert Langreth
Coronavirus Is No Ebola, and That Presents a Different Problem

(Bloomberg) -- Ebola kills half of the people who get it. China’s last worrying viral outbreak, SARS, killed 10%.

The new coronavirus that originated in the Chinese city of Wuhan appears far less fatal, with about 2% of the 6,000 confirmed cases dying. For many, the illness is about as serious as a cold or flu.

That seems like good news, but it’s exactly what worries the scientists and public health experts who study infectious disease ranging from the terrifying to the mundane.

“These hot viruses are very scary and very deadly, but unless they land in the middle of Heathrow Airport or another densely populated place, they aren’t likely to be long-lasting,” said Jennifer Rohn, head of the center for urological biology at the University College London and an expert in pandemics. “They burn fast, and burn through the population. A virus needs a host to survive.” 

In an epidemiological twist of fate, the coronavirus’s mildness may help it spread undetected until it hits the most vulnerable people. Experts are concerned that it could find a devastating “sweet spot”—mild enough that some patients will go about their normal routines and spread the virus far and wide, triggering an increase in deaths. And if some patients may spread the virus when they have mild or no symptoms at all, as Chinese officials have asserted, that would undercut efforts to halt transmission.

The coronavirus has been compared to the flu, which every year infects 10 million to 50 million people in the U.S., leaving tens of thousands of people dead, according to the U.S. Centers for Disease Control and Prevention. It’s a mild-mannered serial killer. The aggressive response to the coronavirus is meant to stop the new pathogen from becoming a deadlier copycat.

“A relatively mild virus can cause a lot of damage if a lot of people get it,” Michael Ryan, director of the World Health Organization’s Emergencies Programme, said at a briefing Wednesday.

“A virus needs a host to survive.”

Behind the decisions to lock down travel for tens of millions in China, isolate suspected cases and put the public and health workers on high alert is a simple but worrying piece of math: If the new coronavirus somehow were to infect 60 million Americans as the swine flu did in 2009 and 2010, but with the same 2% death rate reported in China for the new virus, it could kill over 1 million people.

“Even if only 1% of people who are infected die, if it can spread globally, that will be a lot of people,” said Christian Althaus, a computational epidemiologist at the University of Bern in Switzerland.

So far, the vast majority of the 6,000 global cases of the new coronavirus, known for now as 2019-nCov, have been contained to China.

But the disease has spread inside the world’s most populous nation, a major hub of travel and trade for the region, with cases emerging in Beijing, Shanghai and elsewhere. There are early reports of spread in other countries, as well. Four people in Germany were infected by a coworker visiting from China who didn’t get sick until her plane ride back. In Vietnam, a Chinese man from Wuhan spread the disease to his son there during a visit to the country, during a trip where the infected family traveled around the country on planes, trains, and taxis.

Inside China, the actual case count may be far higher than has been reported. One estimate says the number of infections may have hit more than 26,000 by Jan. 28, according to research from Jinan University published in the biology preprint website, Biorxiv.

Within China, “what the numbers are telling us is this is a very serious situation and the virus is spreading in a very concerning way,” said Michael Olsterholm, director of the the Center for Infectious Disease Research and Policy at the University of Minnesota. So far, it appears “it is going to be much more difficult to control than SARS.”

Viruses are more or less helpless on their own. Without a living thing to make their home, they can’t reproduce and spread. Often, that host may be an animal, and the virus makes the jump into people who come into contact with a natural reservoir of the disease.

When an outbreak happens, isolating people isolates the virus. Hospital gowns and masks stop it from spreading through the air or in bodily fluids. Quarantines keep sick people away from new, healthy hosts. The perfect virus makes people sick enough to spread—sneezing up droplets of germ-laden mist into the air, or leaving a thin residue from a wiped nose on a subway pole—without making them so sick or killing them so quickly that they never get the chance to pass it on.

“There is definitely a sweet spot,” said Rohn, the University College London pandemic expert. “The minute you run out of people, it’s game over for that virus. It’s a balance the virus needs to strike.”

Coronaviruses were long thought to mostly cause cold-like symptoms in humans. But in 2002 and 2003, the coronavirus SARS caused more than 8,000 cases and killed around 800 after it emerged in southern China—a roughly 10% mortality rate. In part because most cases were severe and easily recognized, it was contained within months, despite an initial period of uncontained spread because of China’s slow response. 

“Public health controlled SARS because SARS let it, because you could recognize and isolate disease,” said Mark Denison, director of infectious diseases and pediatrics professor at the Vanderbilt University School of Medicine, who has studied antiviral drugs against coronaviruses. Health authorities have noted that the latest outbreak’s death rate, now around 2%, may drop as more mild cases are discovered.

In 2009 and 2010, another new pathogen, the H1N1 “swine flu” virus, raced around the world like wildfire. It eventually infected nearly 61 million Americans, though it was so mild that many didn’t know they had it. It still caused more than 12,000 deaths in the U.S., a number that’s actually lower than what is normally seen during a typical flu season.

“We are still trying to figure out where this is on the spectrum between SARS, where the vast majority of transmission occurs from very sick people, to something like influenza,” said Julie Gerberding, who was the director of the CDC during the SARS outbreak and now works as the chief patient officer at Merck & Co. “This is probably somewhere in between those two extremes, but where it’s going to fall is a little bit too early to say. That pertains to the mortality figures as well.”

In the coronavirus outbreak, more than a fifth of confirmed patients have developed serious illnesses, according to figures from the Chinese government. Many are elderly, or have underlying health conditions, that put them more at risk. But people with milder cases may keep going to work, traveling, shopping and spreading the virus. 

“If this is a mild infection that only in rare circumstances causes pneumonia or death, many people would probably breathe a sigh of relief,” said Amesh Adalja, an infectious disease expert at Johns Hopkins University in Baltimore. “But it’s often a trade-off. You want to have this contained.”

Whatever happens with the Wuhan outbreak, it’s not going to be the last time a new coronavirus emerges from bats or other animals and starts infecting people. In the last two decades, the world has dealt with two significant Ebola outbreaks, another coronavirus disease, MERS, in the Middle East, and SARS. People will keep bumping into new viruses, ones that humans have never before encountered and to which they have no natural immunity, and have developed no drugs or vaccines. 

“There is every reason to believe these events are going to continue to occur,” said Mark Feinberg, a former Merck vaccine executive and president of the International AIDS Vaccine Initiative. “We need to take them very, very seriously.”

(Adds quote from WHO official in the seventh paragraph.)

--With assistance from Jason Gale.

To contact the authors of this story: Michelle Cortez in New York at mcortez@bloomberg.netRobert Langreth in New York at rlangreth@bloomberg.net

To contact the editor responsible for this story: Drew Armstrong at darmstrong17@bloomberg.net, Timothy Annett

For more articles like this, please visit us at bloomberg.com

Subscribe now to stay ahead with the most trusted business news source.

©2020 Bloomberg L.P.